Ying-nan Wang

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Correction: CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.

Correction: CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.

Journal: Oncogene

Published: August 07, 2025

Erratum: Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation: Erratum.

Erratum: Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation: Erratum.

Journal: Theranostics

Published: May 14, 2025

Correction: LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.

Correction: LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.

Journal: Molecular cancer

Published: January 26, 2025

Dissecting small cell carcinoma of the esophagus ecosystem by single-cell transcriptomic analysis.

Dissecting small cell carcinoma of the esophagus ecosystem by single-cell transcriptomic analysis.

Journal: Molecular cancer

Published: December 01, 2024

Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors.

Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors.

Journal: Cancer cell

Published: August 09, 2024

Individualized metagenomic network model for colorectal cancer diagnosis: insights into viral regulation of gut microecology.

Individualized metagenomic network model for colorectal cancer diagnosis: insights into viral regulation of gut microecology.

Journal: Briefings in bioinformatics

Published: April 08, 2024

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.

Journal: Nature medicine

Published: July 30, 2023

Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc.

Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc.

Journal: Oncogene

Published: January 28, 2022

Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancer.

Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancer.

Journal: Nature communications

Published: April 27, 2021

Elevated peripheral blood neutrophil-to-lymphocyte ratio is associated with an immunosuppressive tumour microenvironment and decreased benefit of PD-1 antibody in advanced gastric cancer.

Elevated peripheral blood neutrophil-to-lymphocyte ratio is associated with an immunosuppressive tumour microenvironment and decreased benefit of PD-1 antibody in advanced gastric cancer.

Journal: Gastroenterology report

Published: March 16, 2021

FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis.

FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis.

Journal: Oncogene

Published: January 28, 2021

Germline mutational profile of Chinese patients under 70 years old with colorectal cancer.

Germline mutational profile of Chinese patients under 70 years old with colorectal cancer.

Journal: Cancer communications (London, England)

Published: August 28, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026